ZA200707315B - Substituted 5-phenyl pyrimidines I in therapy - Google Patents

Substituted 5-phenyl pyrimidines I in therapy

Info

Publication number
ZA200707315B
ZA200707315B ZA200707315A ZA200707315A ZA200707315B ZA 200707315 B ZA200707315 B ZA 200707315B ZA 200707315 A ZA200707315 A ZA 200707315A ZA 200707315 A ZA200707315 A ZA 200707315A ZA 200707315 B ZA200707315 B ZA 200707315B
Authority
ZA
South Africa
Prior art keywords
therapy
substituted
phenyl pyrimidines
pyrimidines
phenyl
Prior art date
Application number
ZA200707315A
Other languages
English (en)
Inventor
Rheinheimer Joachim
Grote Thomas
Mueller Bernd
Schieweck Frank
Schwoegler Anja
Jabs Thorsten
Blettner Carsten
Nave Barbara
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA200707315B publication Critical patent/ZA200707315B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200707315A 2005-01-31 2007-08-29 Substituted 5-phenyl pyrimidines I in therapy ZA200707315B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05001955 2005-01-31

Publications (1)

Publication Number Publication Date
ZA200707315B true ZA200707315B (en) 2008-11-26

Family

ID=34933530

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200707315A ZA200707315B (en) 2005-01-31 2007-08-29 Substituted 5-phenyl pyrimidines I in therapy

Country Status (19)

Country Link
US (1) US20080146593A1 (zh)
EP (1) EP1845991A2 (zh)
JP (1) JP2008528535A (zh)
KR (1) KR20070104893A (zh)
CN (1) CN101111250A (zh)
AR (1) AR054220A1 (zh)
AU (1) AU2006208621B2 (zh)
BR (1) BRPI0607108A2 (zh)
CA (1) CA2595958A1 (zh)
EA (1) EA014098B1 (zh)
IL (1) IL184375A0 (zh)
MX (1) MX2007008397A (zh)
NZ (1) NZ556448A (zh)
PE (1) PE20061042A1 (zh)
TW (1) TW200637556A (zh)
UA (1) UA87895C2 (zh)
UY (1) UY29352A1 (zh)
WO (1) WO2006079556A2 (zh)
ZA (1) ZA200707315B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010502674A (ja) * 2006-09-07 2010-01-28 ノイロサーチ アクティーゼルスカブ カリウムチャンネル調節剤として有用なピリジニル−ピリミジン誘導体
TW200836741A (en) * 2007-01-11 2008-09-16 Basf Ag 2-substituted pyrimidines I in therapy
KR100936278B1 (ko) * 2007-12-14 2010-01-13 한국생명공학연구원 단백질 포스파타제의 활성을 억제하는 피리미딘 유도체또는 이의 약학적으로 허용가능한 염을 유효성분으로함유하는 암 예방 및 치료용 조성물
AU2009282567B2 (en) * 2008-08-20 2014-10-02 Merck Sharp & Dohme Corp. Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
CZ305457B6 (cs) 2011-02-28 2015-09-30 Ústav organické chemie a biochemie, Akademie věd ČR v. v. i. Pyrimidinové sloučeniny inhibující tvorbu oxidu dusnatého a prostaglandinu E2, způsob výroby a použití
WO2019134082A1 (en) * 2018-01-04 2019-07-11 Wuxi Advant Biotechnology Co., Ltd. Novel pyrimidine derivatives as mth1 inhibitors

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4006235A (en) * 1973-03-23 1977-02-01 Burroughs Wellcome Co. Treating CNS lymphoma
GB8314643D0 (en) * 1983-05-26 1983-06-29 Wellcome Found Pyrimidine derivatives
GB9012316D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
GB9700664D0 (en) * 1997-01-14 1997-03-05 British Tech Group Anti-cancer agents
MXPA03008121A (es) 2001-03-15 2003-12-12 Basf Ag 5-fenilpirimidinas, metodos y productos intermedios para su produccion y uso de las mismas para controlar hongos patogenicos.
AP2003002924A0 (en) * 2001-06-12 2003-12-31 Neurogen Corp 2,5-diarylpyrazines, 2,5 - diarylpyridines and 2,5 - diarylpyrimidines as CRF1 receptor modulators
NZ533265A (en) * 2001-11-19 2006-05-26 Basf Ag 5-Phenylpyrimidines, their preparation, compositions comprising them and their use
WO2003070721A1 (de) * 2002-02-21 2003-08-28 Basf Aktiengesellschaft 2-(2-pyridyl)-5-phenyl-6-aminopyrimidine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen
DE60336735D1 (de) * 2002-07-22 2011-05-26 Orchid Res Lab Ltd Neue biologischaktive molekü le
US7371758B2 (en) * 2003-03-13 2008-05-13 National Science & Technology Development Agency Antimalarial pyrimidine derivatives and methods of making and using them
MXPA05011549A (es) * 2003-05-20 2005-12-15 Basf Ag Pirimidinas 2 - sustituidas.
US7317015B2 (en) * 2003-07-24 2008-01-08 Basf Aktiengesellschaft 2-Substituted pyrimidines
WO2005030216A1 (en) * 2003-09-24 2005-04-07 Wyeth Holdings Corporation 5-arylpyrimidines as anticancer agents
US20050070712A1 (en) * 2003-09-26 2005-03-31 Christi Kosogof Pyrimidine derivatives as ghrelin receptor modulators
DE102004003493A1 (de) * 2004-01-23 2005-08-11 Bayer Cropscience Ag 5-Phenylpyrimidine
US20080132522A1 (en) * 2004-07-14 2008-06-05 Basf Aktiengesellschaft 2-Substituted Pyrimidines, Method for Their Production and Their Use for Controlling Pathogenic Fungi

Also Published As

Publication number Publication date
UA87895C2 (en) 2009-08-25
NZ556448A (en) 2010-12-24
BRPI0607108A2 (pt) 2010-03-09
AU2006208621A1 (en) 2006-08-03
UY29352A1 (es) 2006-08-31
AU2006208621B2 (en) 2011-08-11
EA200701582A1 (ru) 2008-02-28
CN101111250A (zh) 2008-01-23
AR054220A1 (es) 2007-06-13
CA2595958A1 (en) 2006-08-03
MX2007008397A (es) 2007-09-07
WO2006079556A3 (en) 2006-09-21
TW200637556A (en) 2006-11-01
IL184375A0 (en) 2007-10-31
EP1845991A2 (en) 2007-10-24
EA014098B1 (ru) 2010-08-30
US20080146593A1 (en) 2008-06-19
JP2008528535A (ja) 2008-07-31
WO2006079556A2 (en) 2006-08-03
KR20070104893A (ko) 2007-10-29
PE20061042A1 (es) 2006-11-20

Similar Documents

Publication Publication Date Title
IL181433A0 (en) Pyrimidine derivatives
AP2008004486A0 (en) Pyrimidine derivatives
IL181386A0 (en) Pyrimidine derivatives
EP1724267A4 (en) PYRIMIDINE DERIVATIVE
GB0525080D0 (en) Pyrimidine derivatives
GB0525083D0 (en) Pyrimidine derivatives
GB0415364D0 (en) Pyrimidine derivatives
HK1104553A1 (en) Pyrimidine derivatives
HK1121062A1 (en) Pyrimidine compounds
IL195731A0 (en) Pyrimidine derivatives useful in the treatment of cancer
GB0509824D0 (en) Therapeutic foam
IL186939A0 (en) Pyrimidine derivatives and their use as
HK1205935A1 (zh) 非碎石性的腎結石療法
GB0525081D0 (en) Pyrimidine derivatives
GB0400700D0 (en) Compounds useful in therapy
GB0509819D0 (en) Therapeutic foam
GB0415367D0 (en) Pyrimidine derivatives
ZA200707315B (en) Substituted 5-phenyl pyrimidines I in therapy
ZA200810524B (en) Pyrimidine derivatives useful in the treatment of cancer
GB0401384D0 (en) Compounds useful in therapy
GB0424972D0 (en) Pyrimidine compounds
GB0505714D0 (en) Improvements in sauna heating
ZA200804208B (en) Oxygen linked pyrimidine derivatives
AU307130S (en) Handbag
AU308515S (en) Handbag